Yanping Izak Harville
Researcher
University of Arkansas for Medical Sciences
unknown
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Yanping Izak Harville's research focuses on understanding the molecular and immunological underpinnings of various disease states. Recent publications investigate the role of SOD1 as a prognostic biomarker for acute kidney injury following cardiothoracic surgery, and the function of IGFBP-1 in the prognosis and pathophysiology of acute kidney injury. Harville has also explored the immunological response to sequential SARS-CoV-2 mRNA vaccination in transgenic mice, specifically examining the induction of anti-idiotype (anti-ACE2) antibodies. Additionally, research has examined the predictive capabilities of HLA-DR-DQ associations in conjunction with the PLASMIC score for acquired thrombotic thrombocytopenic purpura (aTTP), and differentiating it from other thrombotic microangiopathies. Harville has collaborated with Christian Herzog, Luis A. Juncos, Joseph H. Holthoff, and Nithin Karakala on multiple publications.
Metrics
- h-index: 2
- Publications: 4
- Citations: 8
Selected Publications
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025) DOI
- Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice (2025) DOI
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies (2024) DOI
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics